Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05814614
Other study ID # NL8301905822
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 25, 2023
Est. completion date May 1, 2026

Study information

Verified date March 2024
Source Leiden University Medical Center
Contact Dorien Bennink, MSc
Phone +31715299763
Email d.bennink@lumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the effect of pelvic physical therapy with different types of electrical stimulation(ES) for bladder complaints in people with Parkinson's disease. The main question it aims to answer is: What is the effect of pelvic physical therapy with ES for bladder complaints in people with Parkinson's disease. Secondary question: What is the most effective type of ES on bladder complaints in people with Parkinson's disease. Participants will be randomized into three groups. Two different kinds of ES and a sham group. Participants will receive eight session of pelvic physical therapy. Pelvic physical therapy consists of e.g. bladder training, pelvic floor muscle exercises and biofeedback.


Description:

Parkinson's disease (PD) is the second most common degenerative neurological disease in the elderly. PD is predominantly a movement disorder. In addition, PD is associated with non-motor and autonomic symptoms. Over 75% of PD patients, experience lower urinary tract symptoms (LUTS), one of the most common autonomic symptoms. LUTS consists of urgency, frequency and nocturia with or without urinary incontinence (UI). More than 60% of PD patients experience nocturia. LUTS have a negative impact on Quality of Life(QoL), increases the risk of falls are a barrier to exercise and may lead to early admission into care. Therefore, this potentially increases healthcare related costs. First treatment options for LUTS in the general population are conservative therapy and medication. Conservative therapy consists of e.g., behavioral advice, bladder training, pelvic floor muscle exercises provided by a pelvic physical therapist(PPT) and, electrical stimulation(ES). Knowledge of the effectiveness of conservative treatment options for LUTS in PD is limited. Although ES is used effectively in patients with LUTS, it has not yet been studied in PD patients. ES has hardly any side effects, but there is uncertainty about optimal ES parameters. Objective: to study the effectiveness of pelvic physical therapy and ES in patients with PD suffering from LUTS. Study design: Randomized Controlled Trial (RCT). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Questionnaires are online, allowing participants to complete the questionnaires at home at a convenient time. Participants may have direct benefits of participating in this study. Participants included in the study will have two additional visits to a research PPT that will last one hour each, at baseline and after treatment. During this visit, a digital pelvic floor muscle (PFM) assessment and an EMG measurement of the PFM will be performed. EMG measurement will be done with a small anal- or vaginal probe. No risks are associated with the use of this probe. Participants will be referred to local PPT's close to the subjects home address for the treatment sessions. Intervention: eight treatment sessions of 30 minutes pelvic physical therapy over a 10-week period. The intervention consists of bladder- and behavioral advice, pelvic floor muscle exercises (PFME), urge suppression techniques, biofeedback and ES with an intra anal or intra vaginal probe. The group is divided into three groups. Group 1: ES with small pulse duration, group 2: ES with broad pulse duration, group 3: (control group) receiving sham ES. No adverse events are expected since pelvic physical therapy and ES in LUTS is usual care in the general population in the Netherlands. Expected burden for the participants is very low.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date May 1, 2026
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Parkinson's disease - = 18 years of age - Self-reported LUTS - Stable Parkinson's medication for at least three months - Able and willing to independently read and fill in questionnaires in the Dutch language, sufficient understanding of Dutch language - Able to independently visit a pelvic physical therapy practice Exclusion Criteria: - Patients with other neurological diseases - Surgery in the pelvic region in the last year - Cancer or cancer treatment in the pelvic region - Pregnancy - Current urinary tract infection - Pure stress urinary incontinence without urgency, frequency, nocturia - Botox, PTNS or pelvic physical therapy in the last year - Sacral neuromodulator - Pacemaker and Implantable cardioverter defibrillator (ICD) - Deep Brain stimulation (DBS)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
pelvic physical therapy
Pelvic floor muscle exercises, biofeedback, bladder training

Locations

Country Name City State
Netherlands Leiden Univesity Medical Center Leiden Zuid Holland

Sponsors (3)

Lead Sponsor Collaborator
Leiden University Medical Center Royal Dutch Society for Physical Therapy, The Dutch Brain Foundation

Country where clinical trial is conducted

Netherlands, 

References & Publications (3)

Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol. 2005 Nov;252(11):1310-5. doi: 10.1007/s00415-005-0855-3. Epub 2005 May 18. — View Citation

McDonald C, Rees J, Winge K, Newton JL, Burn DJ. Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial. Neurology. 2020 Mar 31;94(13):e1427-e1433. doi: 10.1212/WNL.0000000000008931. Epub 2020 Feb 13. — View Citation

Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H; Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016 Jun;35(5):551-63. doi: 10.1002/nau.22764. Epub 2015 Mar 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in International Prostate Symptom Score (IPSS) Questionnaire of bladder function and urination, of last month, validated for men and
women, 6-point-scale; contains 8 items, 3 about storage of urine, 4 about urination and 1 of quality of life.
Total score of 0-35, with a minimal important difference(MID) of 3, validated in the Netherlands (MID 5.2) A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.
The IPSS is the most prevalent patient-administered questionnaire used in urology.
Change from baseline at 12 weeks
Secondary Change in International Consultation on Incontinence Questionnaire-Urinary Incontinence Short form (ICIQ-UI SF) The validated ICIQ-UI SF measures frequency, severity and, impact on QoL in men and women. The ICIQ-UI SF consists of 4 questions on: frequency or urinary incontinence, amount of leakage, overall impact of urinary incontinence, self-diagnostic item. The score ranges between 0-21. A higher score represents worse QoL. Change from baseline at 12 weeks; at 24 weeks; at one year
Secondary Change International Consultation on Incontinence Questionnaire-Lower Urinary Tract quality of life (ICIQ-LUTSqol) The validated ICIQ-LUTSqol measures QoL with particular reference to social effects.The ICIQ-LUTSqol consists of 20 questions. Total score ranges between 19-76 with greater values indicating increased impact on QoL. Bother scales are not incorporated in the overall score but indicate impact of individual symptoms for the patient. Change from baseline at 12 weeks; at 24 weeks; at one year
Secondary Change in 24 hour bladder diary, bladder volume 24 hour bladder diary: change in mean of bladder volume. Normal bladder volume ranges between: 250-500ml. Change from baseline at 12 weeks
Secondary Change in 24 hour bladder diary, frequency of micturition 24 hour bladder diary, change in frequency of micturition. Number of micturition's in 24 hours. Normal frequency with fluid intake of 1.5-2 liters is 6-8 times in 24 hour. Change from baseline at 12 weeks
Secondary Change in 24 hour bladder diary, urgency 24 hour bladder diary change in urgency scale: patient perception of intensity of urgency
scale(PPIUS). 0 No urgency I felt no need to empty my bladder, but did so for other reasons.
Mild urgency I could postpone voiding as long as necessary, without fear of wetting myself.
Moderate urgency I could postpone voiding for a short while, without fear of wetting myself.
Severe urgency I could not postpone voiding, but had to rush to the toilet in order not to wet myself.
Urge incontinence I leaked before arriving to the toilet.
A higher score on the PPIUS implicates more severe urgency complaints.
Change from baseline at 12 weeks
Secondary Change in 24 hour bladder diary, urinary incontinence 24 hour bladder diary change in urinary incontinence episodes. Number of urinary incontinence episodes in 24 hours. Change from baseline at 12 weeks
Secondary Change in International Prostate Symptom Score (IPSS) Questionnaire of bladder function and urination, of last month, validated for men and women, 6-point-scale; contains 8 items, 3 about storage of urine, 4 about urination and 1 of quality of life.
Total score of 0-35, with a minimal important difference(MID) of 3, validated in the Netherlands (MID 5.2).
A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.
The IPSS is the most prevalent patient-administered questionnaire used in urology.
Change from baseline at 24 weeks and at one year.
Secondary Change in International Consultation on Incontinence Questionnaire-Overactive Bladder Short form (ICIQ-OAB) The validated ICIQ-OAB evaluating overactive bladder and related impact on quality of life (QoL) and outcome of treatment in men and women, measure the impact of urinary frequency, urgency, urge incontinence and nocturia symptoms. It consist of 6 questions. The scores range from 0-16, overall score with greater values indicating increased symptom severity. Change from baseline at 12 weeks; at 24 weeks; at one year
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A
Recruiting NCT03618901 - Rock Steady Boxing vs. Sensory Attention Focused Exercise N/A